Meningococcal vaccine group B conjugate (Sanofi Pasteur)

N/A

Report date: 2024/10/21 20:00:47

Base Information

Drug NameMeningococcal vaccine group B conjugate (Sanofi Pasteur)

Drug Alias NameGroup B meningococcal polysaccharide conjugate vaccine(sanofi pasteur)

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningitis, Meningococcal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi Pasteur

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSanofi Pasteur

Active IndicationsN/A

Inactive IndicationsMeningitis, Meningococcal

Other Information

ATC CodeN/A